PATH FinaBio FeaturedImage

How PATH and FinaBio Make Vaccines Affordable

PATH (path.org), an organization promoting health in low income countries, has published an article on their smaller partners, including Fina Biosolutions. FinaBio has worked with PATH on conjugate vaccines for malaria, pneumo, meningococcal, Group B strep and other indications. PATH is assisting FinaBio in bringing our CRM197 conjugate vaccine carrier protein to GMP manufacture.

Read more about FinaBio’s partnership with PATH.

 

Please enter your details to download the PDF
    
WEBINAR ANNOUNCEMENT
Genetic Engineering News presents
Exploring
Novel Vaccine
Charaterization
Thurs, 28 May 2020
11:00 AM - 12:00 PM EST
featuring
CLICK HERE
to register

Dr. Andrew Lees
Founder and Scientific Director
Fina Biosolutions